Evidence map›Paper›PMID 23705774›Full record

ArticleAlzheimer's research & therapy2013

Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease.

Scott J Webster, Adam D Bachstetter, Linda J Van Eldik

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 146 citations in OpenAlex.

  1. Exploring the Neuroprotective Effects of Walnut (International journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. The role ofFrontiers in neuroscience · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Scott J WebsterSanders-Brown Center on Aging, 800 S. Limestone, University of Kentucky, Lexington, KY 40536, USA.
Adam D BachstetterSanders-Brown Center on Aging, 800 S. Limestone, University of Kentucky, Lexington, KY 40536, USA.
Linda J Van EldikSanders-Brown Center on Aging, 800 S. Limestone, University of Kentucky, Lexington, KY 40536, USA ; Department of Anatomy and Neurobiology, 800 S. Limestone, University of Kentucky, Lexington, KY 40536, USA.
University of Kentucky · US

Funding

TROPIC, CHOLINERGIC AND PATHOLOGIC CHANGES IN ALZHEIMER'S DISEASEP01AG005119 · NIA · UNIVERSITY OF KENTUCKY · PI MARKESBERY, WILLIAM R · 1985 to 2012
$15.4M
Modulation of CNS Proinflammatory Cytokine ProductionR01NS064247 · NINDS · UNIVERSITY OF KENTUCKY · PI VAN ELDIK, LINDA J · 2010 to 2013
$1.1M
Harnessing microglia towards repair vs. damage: Does p38 MAPK hold the reins?F32AG037280 · NIA · UNIVERSITY OF KENTUCKY · PI BACHSTETTER, ADAM D · 2010 to 2012
$126k
NIA NIH HHS F32 AG037280NIA NIH HHS P01 AG005119NINDS NIH HHS R01 NS064247
6 · The paper itself

Abstract

introductionDespite the extensive mechanistic and pathological characterization of the amyloid precursor protein (APP)/presenilin-1 (PS-1) knock-in mouse model of Alzheimer's disease (AD), very little is known about the AD-relevant behavioral deficits in this model. Characterization of the baseline behavioral performance in a variety of functional tasks and identification of the temporal onset of behavioral impairments are important to provide a foundation for future preclinical testing of AD therapeutics. Here we perform a comprehensive behavioral characterization of this model, discuss how the observed behavior correlates with the mechanistic and pathological observations of others, and compare this model with other commonly used AD mouse models.

methodsFOUR DIFFERENT GROUPS OF MICE RANGING ACROSS THE LIFESPAN OF THIS MODEL (TEST GROUPS: 7, 11, 15, and 24 months old) were run in a behavioral test battery consisting of tasks to assess motor function (grip strength, rotor rod, beam walk, open field ambulatory movement), anxiety-related behavior (open field time spent in peripheral zone vs. center zone, elevated plus maze), and cognitive function (novel object recognition, radial arm water maze).

resultsThere were no differences in motor function or anxiety-related behavior between APP/PS-1 knock-in mice and wild-type counterpart mice for any age group. Cognitive deficits in both recognition memory (novel object recognition) and spatial reference memory (radial arm water maze) became apparent for the knock-in animals as the disease progressed.

conclusionThis is the first reported comprehensive behavioral analysis of the APP/PS1 knock-in mouse model of AD. The lack of motor/coordination deficits or abnormal anxiety levels, coupled with the age/disease-related cognitive decline and high physiological relevance of this model, make it well suited for utilization in preclinical testing of AD-relevant therapeutics.

Indexed as

Alzheimer's diseaseamyloid precursor protein/presenilin-1anxiety behaviorcognitionlearning and memorymotor behaviorrecognition memoryspatial reference memorytransgenic mouse model

Identifiers

PMID23705774
PMCPMC3706792
OpenAlexW2171542393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.